Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multimodal Imaging
100%
Targeted Nanoparticles
100%
Receptor for Advanced Glycation End Products
100%
Product Level
27%
Human Serum Albumin
18%
Non-ischemic
18%
Murine Model
18%
Electron Microscopy
9%
Dynamic Light Scattering
9%
Disease States
9%
Whole-body
9%
Diabetes
9%
Hindlimb
9%
HUVEC Cells
9%
Nuclear Magnetic Resonance
9%
Optical Imaging
9%
Related Conditions
9%
Histological Assessment
9%
Positron Emission Tomography-computed Tomography (PET-CT)
9%
Rhodamine B (Rh B)
9%
Cellular Level
9%
Non-invasive Assessment
9%
Peripheral Arterial Disease
9%
Binding Capability
9%
Multiple Diseases
9%
Cellular Tissue
9%
Biodistribution
9%
Ischemic Tissue
9%
Blood Clearance
9%
Imaging Agents
9%
Polyamidoamine (PAMAM)
9%
PET Imaging
9%
Targeting Property
9%
Molecular Imaging Agents
9%
Medicine and Dentistry
Multimodal Imaging
100%
Nanoparticle
100%
Advanced Glycation End Product Receptor
100%
Hindlimb
27%
Radioactive Tracer
27%
Ischemia
18%
Human Serum Albumin
18%
Imaging Agent
18%
Electron Microscopy
9%
Photon Correlation Spectroscopy
9%
Molecular Imaging
9%
Diabetes
9%
Positron Emission Tomography-Computed Tomography
9%
Positron Emission Tomography
9%
Rhodamine
9%
Arteriosclerosis Obliterans
9%
Dendrimer
9%
Biodistribution
9%
Optical Imaging
9%
Comorbidity
9%
Polyethylene Terephthalate
9%
NMR Spectroscopy
9%
Chelating Agent
9%
Plasma Clearance
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Advanced Glycation End Product Receptor
100%
Copper 64
45%
Tracer
27%
Polyethylene Terephthalate
27%
Ischemia
18%
Human Serum Albumin
18%
Chelating Agent
9%
Electron Microscopy
9%
Rhodamine
9%
Peripheral Occlusive Artery Disease
9%
Biodistribution
9%
Dendrimer
9%
Comorbidity
9%
Light Scattering
9%
Poly(amidoamine)
9%
Immunology and Microbiology
Glycation
100%
Serum (Blood)
18%
Albumin
18%
Light Scattering
9%
Electron Microscopy
9%
Molecular Imaging
9%
Positron Emission Tomography
9%
Comorbidity
9%
Magnetism
9%
Optics
9%
Positron Emission Tomography-Computed Tomography
9%
Plasma Clearance
9%